Methylfolate (L-5-MTHF)
L-5-methyltetrahydrofolate is folate already in its active, circulating form, and it's the one donating methyl groups for DNA synthesis, homocysteine remethylation, and neural tube closure in those first critical weeks of embryonic development. Synthetic folic acid has to pass through the DHFR and MTHFR conversion steps to become useful. This form skips both, so your status isn't hostage to how well those enzymes happen to be working.
Evidence
Strong, and this is not a fringe opinion: randomized and population data both show periconceptional folate supplementation substantially cuts neural tube defect risk. That's the basis for public-health recommendations everywhere. Where the evidence thins out: whether this specific methylfolate form clinically beats plain folic acid for pregnancy outcomes. That claim is only moderate. The strong grade belongs to folate adequacy in general, not to methylfolate specifically getting a proven edge over the cheaper form.
Interactions
Certain anticonvulsants (valproate, carbamazepine), methotrexate, sulfasalazine, and trimethoprim interfere with folate metabolism and change requirements; high folate can mask B12 deficiency by correcting the anemia while neurologic damage continues. Coordinate dosing with any of these medications through a clinician.
Cautions
Confirm the dose and form with your OB or midwife; folate needs are individualized and higher targeted doses require medical supervision, especially with a personal or family history of neural tube defects. Adequate B12 status should be assessed alongside folate. This is educational information for discussion with a clinician, not a prescription.
Food sources
Leafy greens (spinach, romaine), lentils and beans, asparagus, avocado, citrus, and beets; many grains are fortified with folic acid.
